American Society of Addiction Medicine
American Society of Addiction Medicine
ASAM Weekly Special Episode: Rapid Initiation of Injection Naltrexone for OUD | Dr. Matisyahu Shulman & Dr. Adam Bisaga
ASAM Weekly Special Episode: Rapid Initiation of Injection Naltrexone for OUD | Dr. Matisyahu Shulman & Dr. Adam Bisaga
ASAM Weekly Special Episode: Rapid Initiation of Injection Naltrexone for OUD | Dr. Matisyahu Shulman & Dr. Adam Bisaga
Tuesday 6th August 2024
Drs. Shulman and Bisaga discuss their groundbreaking study on rapid initiation of injection naltrexone for opioid use disorder. Tune in for key insights.
32 minutes
Informative
Inspiring
Hopeful
Educational
Supportive
About this podcast
Author:
American Society of Addiction Medicine
Overview:
Categories:
Innovative Treatments & Recovery Paths
Navigating Alcohol Dependency
Family Recovery from Addiction
Nutritional Pathways to Recovery
Navigating Intimate Relationships
Links:
Visit site
Episodes:
131 (View all)
Do you want to link to this podcast?
Get the buttons here!Revolutionising OUD Treatment: Rapid Naltrexone Initiation
Episode Overview
- Rapid initiation of injection naltrexone can significantly reduce the time needed to start treatment.
- The study showed twice as many patients successfully began treatment with the rapid approach compared to traditional methods.
- Safety concerns were minimal and manageable, though close monitoring is essential.
- Offering all available treatment options can increase patient engagement and success rates.
- Real-world implementation requires dedicated training and resources but is feasible.
We were able to find that it was, from a statistical perspective, better to use the rapid approach.
Get ready for an eye-opening discussion as Dr. Nick Athanasiou sits down with Drs. Matisyahu Shulman and Adam Bisaga to chat about their recent study on the rapid initiation of injection naltrexone for opioid use disorder (OUD). These experts dive into the nitty-gritty of their research, which explores a faster method to get patients started on extended-release naltrexone, a medication used to treat OUD.
The conversation is packed with insights on the challenges and successes of implementing this rapid approach in real-world settings. Dr. Shulman and Dr. Bisaga share their experiences and findings, highlighting the potential benefits and some unexpected hurdles they encountered along the way. They also discuss the importance of offering all available treatment options to patients, particularly those who might be hesitant about traditional agonist-based treatments like methadone or buprenorphine.
This episode is a must-listen for anyone interested in cutting-edge addiction treatment methods and the ongoing efforts to improve patient care in the field of addiction medicine. Tune in to learn how this rapid protocol could change the landscape of OUD treatment and why it’s crucial to keep exploring new ways to support those battling addiction.